# EMROSI

NDC: 69489-131
Generic name: Minocycline Hydrochloride Extended-Release
Labeler / Manufacturer: Journey Medical Corporation
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: CAPSULE
Routes: ORAL
Marketing started: 20250301

FDA application: NDA219015

## Active ingredients

- MINOCYCLINE HYDROCHLORIDE: 40 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69489-131"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69489-131
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0899eb25-8807-037c-f66c-141a2696b1c0